Lupin's Nagpur Injectable Facility Receives Six Observations in USFDA Inspection
Lupin’s injectable facility in Nagpur has received six observations from the US Food and Drug Administration (USFDA), following an inspection conducted between the 8th and 16th of September 2025.
Injectable Facility | 19/09/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy